Immunotherapy for Metastatic Kidney Cancer Shows Increased Survival
3 Visninger
• 07/10/23
0
0
Indlejre
administrator
Abonnenter
The immune checkpoint inhibitor Opdivo (nivolumab) has been shown to increase survival for patients with metastatic clear cell kidney cancer (also called renal cell carcinoma, or RCC).
Vis mere
Facebook kommentarer
SORT BY-
Topkommentarer
-
Seneste kommentarer